126 related articles for article (PubMed ID: 15301714)
1. [Cytotoxicity induced by HBsAg gene modified-dendritic cells against hepatocellular carcinoma cell HepG2.2.15].
Yang JY; Ren J; Bai J; Liu DH; Fan L; Si XM; Teng ZH; Yang WT
Ai Zheng; 2004 Aug; 23(8):914-7. PubMed ID: 15301714
[TBL] [Abstract][Full Text] [Related]
2. [Immune response of HBsAg gene-modified dendritic cell-based vaccine in HepG2. 2. 15 hepatocellular carcinoma cells].
Yang JY; Liu WC; Cao DY; Si XM; Teng ZH
Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):728-32. PubMed ID: 18396682
[TBL] [Abstract][Full Text] [Related]
3. Improvement of dendritic-based vaccine efficacy against hepatitis B virus-related hepatocellular carcinoma by two tumor-associated antigen gene-infected dendritic cells.
Yang JY; Cao DY; Xue Y; Yu ZC; Liu WC
Hum Immunol; 2010 Mar; 71(3):255-62. PubMed ID: 20036295
[TBL] [Abstract][Full Text] [Related]
4. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH
Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500
[TBL] [Abstract][Full Text] [Related]
5. Induction of specific cytolytic T lymphocytes using fusions of hepatocellular carcinoma (HCC) patient-derived dendritic cells and allogeneic HCC cell line.
Yin XY; Wang L; Lu MD; Li BJ; Huang JF
Hepatogastroenterology; 2008; 55(81):155-9. PubMed ID: 18507097
[TBL] [Abstract][Full Text] [Related]
6. [Killing effect of dendritic cell vaccine transfected by recombinant adeno-associated virus with hAFP gene fragment on hepatocellular carcinoma cells in vitro].
Sun JH; Ma YL; Peng ME; Bie AG; Li L; Liu L
Zhonghua Zhong Liu Za Zhi; 2010 May; 32(5):334-8. PubMed ID: 20723429
[TBL] [Abstract][Full Text] [Related]
7. [Dendritic cells derived from hematopoietic stem cells pulsed with p53 induce a specific immune response against HMCC97 hepatocellular carcinoma cells].
Jia J; Ren J; Zhang HM; Zhang LW; Guo XT
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Oct; 40(5):489-93. PubMed ID: 18931711
[TBL] [Abstract][Full Text] [Related]
8. Glypican3 in genetically modified human monocyte-derived dendritic cells induced specific cytotoxity against glypican3 overexpressing human hepatocellular carcinoma cells in vitro.
Guo DW; Zhang SY; Hou XZ; Li HW; Jiang XF; Sun WY; We YT; Liang J
Saudi Med J; 2008 Sep; 29(9):1235-40. PubMed ID: 18813403
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cell generated from CD34+ hematopoietic progenitors can be transfected with adenovirus containing gene of HBsAg and induce antigen-specific cytotoxic T cell responses.
Yang JY; Cao DY; Liu WC; Zhang HM; Teng ZH; Ren J
Cell Immunol; 2006 Mar; 240(1):14-21. PubMed ID: 16875681
[TBL] [Abstract][Full Text] [Related]
10. [Antitumor effects and mechanisms of a dendritic cell vaccine which silenced SOCS1 by siRNA, stimulated by OK-432 and pulsed with lysate of HepG2 cells].
Song HF; Zhou J; Pan K; Wang QJ; Wang H; Huang LX; Li YQ; Xia JC
Ai Zheng; 2008 Jul; 27(7):685-91. PubMed ID: 18606059
[TBL] [Abstract][Full Text] [Related]
11. Specific antihepatocellular carcinoma T cells generated by dendritic cells pulsed with hepatocellular carcinoma cell line HepG2 total RNA.
Zhang L; Zhang H; Liu W; Wang H; Jia J; Si X; Ren J
Cell Immunol; 2005 Nov; 238(1):61-6. PubMed ID: 16472793
[TBL] [Abstract][Full Text] [Related]
12. [Inducing hepatocellular carcinoma-specific cytotoxic T lymphocyte response using formed by fusion of FastDCs and allogeneic human hepatocellular carcinoma cells].
Guan X; Leng XS; Peng JR; Wei YH; Wang H; Yuan L
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3332-6. PubMed ID: 16409838
[TBL] [Abstract][Full Text] [Related]
13. [Cytotoxicity of cytotoxic T lymphocytes induced by the dendritic cells phagocytosing PLA-AFP218-226 micospheres Against hepatocellular carcinoma cell lines].
Zhang B; Chen W; Dong W; Cai MY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 May; 37(3):378-80, 448. PubMed ID: 16761412
[TBL] [Abstract][Full Text] [Related]
14. [Induction of specific cytotoxic T lymphocyte response against hepatitis B virus by hepatitis B virus S gene-modified dendritic cells].
Lei CL; Huang CH; Yang Z; Tang XP
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):108-10. PubMed ID: 17653306
[TBL] [Abstract][Full Text] [Related]
15. [GM-CSF gene-modified dendritic cell vaccine enhances antitumor immunity in vitro].
He SB; Sun K; Wang L; Li DC; Zhang YY
Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):410-4. PubMed ID: 20819479
[TBL] [Abstract][Full Text] [Related]
16. Antigen-loaded dendritic cells triggers a specific cytotoxic T lymphocytes immune response against hepatocellular carcinoma: in vitro study.
El-Ashmawy NE; El-Zamarany EA; Khedr EG; El-Bahrawy HA; El-Feky OA
Clin Transl Oncol; 2019 May; 21(5):636-645. PubMed ID: 30368725
[TBL] [Abstract][Full Text] [Related]
17. [An in vitro study of specific antitumor immunity induced by dendritic cells pulsed with tumor cell lysates from patients with hepatocellular carcinoma].
Gao J; Chen M; Peng ML; Ren H
Zhonghua Gan Zang Bing Za Zhi; 2005 Mar; 13(3):198-201. PubMed ID: 15760555
[TBL] [Abstract][Full Text] [Related]
18. Potential therapeutic value of dendritic cells loaded with NY‑ESO‑1 protein for the immunotherapy of advanced hepatocellular carcinoma.
Chen Y; Huang A; Gao M; Yan Y; Zhang W
Int J Mol Med; 2013 Dec; 32(6):1366-72. PubMed ID: 24085111
[TBL] [Abstract][Full Text] [Related]
19. [In vitro anti-tumor effect of CTL induced by HSP70-Id complex-modified dendritic cells].
Wang ZH; Ye Q; Hu ZQ; Ye ZQ; Yu X; Shen GX
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):481-5. PubMed ID: 17147108
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy based on dendritic cells pulsed with CTPFoxM1 fusion protein protects against the development of hepatocellular carcinoma.
Su H; Li B; Zheng L; Wang H; Zhang L
Oncotarget; 2016 Jul; 7(30):48401-48411. PubMed ID: 27351282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
